Pfizer posts revenue of Rs 251.69 crores for quarter ended March 31, 2014
The profit before tax and exceptional items for the year grew by 21 per cent to Rs 339.58 crores
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Shantha’s pentavalent paediatric vaccine prequalified by WHO
Shan5™ is the first vaccine jointly developed by Shantha Biotechnics and Sanofi Pasteur Sanofi Pasteur, the vaccines division of…
May 1-15, 2014
{source}<div data-configid="5690019/7725147" style="width: 600px; height: 387px;" class="issuuembed"></div><script…
Sun Pharma announces manufacturing consolidation
The company has provided the requisite advance written notice of the facility closure to the employee union and all affected…
AstraZeneca rejects Pfizer’s raised bid of $106 billion
AstraZeneca's board said it had 'no hesitation' in rejecting the proposals, which it believed 'substantially undervalue' the…
“We welcome the announcement that USTR will initiate an Out-of-Cycle Review of India”: PhRMA
Appreciates continuing efforts by the U.S. Government, including by the Office of USTR to promote compliance with international…
India remains on USTR Priority Watch List
US trade body announces more in-depth investigation into India's patent laws
WHO’s first global report on antibiotic resistance reveals serious, worldwide threat to public…
The available data reveal that antibiotic resistance is a burgeoning problem in WHO's South-East Asia Region
Court orders temporary halt on Sun Pharma’s $3.2 billion takeover of Ranbaxy
Two individuals filed the petition in the high court of Andhra Pradesh